5 Cheap Healthcare Stocks to Buy in 2023
Three of the 943 hedge funds part of Insider Monkey's database had bought Molecular Partners AG (NASDAQ:MOLN)'s shares during Q4 2022.
Molecular Partners Ag (MOLN)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Suvretta Capital Management Aaron Cowen | 2,221,494 | $10,547,654 | +456% | 0.35% |
| 2. | Biotechnology Value Fund / BVF Inc Mark Lampert | 1,353,968 | $6,458,427 | +206% | 0.21% |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 6,872 | $32,628 | 0% | |
| 2. | 367 | $1,743 | 0% | |
| 3. | 269 | $1,283 | 0% | |
| 4. | 0 | $0 | 0% |
News See All
Molecular Partners AG (NASDAQ:MOLN) Q4 2022 Earnings Call Transcript
Operator: Good day and welcome to the Molecular Partners Publication of Full Year Results 2022 Conference Call. Please note this event is being recorded.
Billionaire Hedge Funds
